Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CAMP4 Therapeutics Corporation”

4 pharma patents match "CAMP4 Therapeutics Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "CAMP4 Therapeutics Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “CAMP4 Therapeutics Corporation” · 30,257 patents in full index Clear search

  1. US 12319916

    Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs

    CAMP4 Therapeutics Corporation · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  2. US 12145963

    Phenothiazine derivatives and uses thereof

    CAMP4 Therapeutics Corporation · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  3. US 11542290

    Phenothiazine derivatives and uses thereof

    CAMP4 Therapeutics Corporation · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  4. US 11266655

    Methods and compositions for treating urea cycle disorders

    CAMP4 Therapeutics Corporation · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted